Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
Identifieur interne : 000271 ( PubMed/Corpus ); précédent : 000270; suivant : 000272Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
Auteurs : Perdita Cheshire ; Scott Ayton ; Kelly L. Bertram ; Helen Ling ; Abi Li ; Catriona Mclean ; Glenda M. Halliday ; Sean S. O'Sullivan ; Tamas Revesz ; David I. Finkelstein ; Elsdon Storey ; David R. WilliamsSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.
Abstract
Preclinical animal models implicate serotonin neurons in the pathophysiology of levodopa (l-dopa)-induced dyskinesias in Parkinson's disease (PD), but effective treatment remains elusive. We examined the relationship between serotonin and l-dopa-induced dyskinesias in a pathologically confirmed cohort of PD patients. We obtained brain tissue from 44 PD cases and 17 age-matched controls and assessed monoamine levels and the serotonin and dopamine transporters in the striatum, and the extent of dopaminergic and serotonergic cell preservation in the substantia nigra (SN) and the dorsal raphe nuclei (DRN), respectively. As expected, PD patients demonstrated a severe loss of all dopaminergic markers, including dopamine (P < 0.0001) and the dopamine transporter (P < 0.0001) in the striatum, and dopaminergic neurons (P < 0.001) in the SN, compared with controls. Marked serotonin loss was observed in the caudate (but not putamen) in PD patients compared with controls (P < 0.001), but no difference was found in the levels of the serotonin transporter in the striatum or density of serotonergic neurons in the DRN between these groups, suggesting a functional but not structural change in the serotonergic system in PD. No difference was seen in levels of serotonergic and dopaminergic markers in the striatum between PD patients with and without dyskinesias, or between cases separated according to the clinical severity of their dyskinesias. The absence of a correlation between striatal serotonin markers and the incidence and severity of l-dopa-induced dyskinesias suggests that an intact and functioning serotonergic system is not a risk factor for developing dyskinesias in PD.
DOI: 10.1002/mds.26144
PubMed: 25649148
Links to Exploration step
pubmed:25649148Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.</title>
<author><name sortKey="Cheshire, Perdita" sort="Cheshire, Perdita" uniqKey="Cheshire P" first="Perdita" last="Cheshire">Perdita Cheshire</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ayton, Scott" sort="Ayton, Scott" uniqKey="Ayton S" first="Scott" last="Ayton">Scott Ayton</name>
<affiliation><nlm:affiliation>The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bertram, Kelly L" sort="Bertram, Kelly L" uniqKey="Bertram K" first="Kelly L" last="Bertram">Kelly L. Bertram</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ling, Helen" sort="Ling, Helen" uniqKey="Ling H" first="Helen" last="Ling">Helen Ling</name>
<affiliation><nlm:affiliation>Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Abi" sort="Li, Abi" uniqKey="Li A" first="Abi" last="Li">Abi Li</name>
<affiliation><nlm:affiliation>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mclean, Catriona" sort="Mclean, Catriona" uniqKey="Mclean C" first="Catriona" last="Mclean">Catriona Mclean</name>
<affiliation><nlm:affiliation>Anatomical Pathology, Alfred Hospital, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
<affiliation><nlm:affiliation>Neuroscience Research Australia and University of New South Wales, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="O Sullivan, Sean S" sort="O Sullivan, Sean S" uniqKey="O Sullivan S" first="Sean S" last="O'Sullivan">Sean S. O'Sullivan</name>
<affiliation><nlm:affiliation>Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Revesz, Tamas" sort="Revesz, Tamas" uniqKey="Revesz T" first="Tamas" last="Revesz">Tamas Revesz</name>
<affiliation><nlm:affiliation>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Finkelstein, David I" sort="Finkelstein, David I" uniqKey="Finkelstein D" first="David I" last="Finkelstein">David I. Finkelstein</name>
<affiliation><nlm:affiliation>The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Storey, Elsdon" sort="Storey, Elsdon" uniqKey="Storey E" first="Elsdon" last="Storey">Elsdon Storey</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Williams, David R" sort="Williams, David R" uniqKey="Williams D" first="David R" last="Williams">David R. Williams</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25649148</idno>
<idno type="pmid">25649148</idno>
<idno type="doi">10.1002/mds.26144</idno>
<idno type="wicri:Area/PubMed/Corpus">000271</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.</title>
<author><name sortKey="Cheshire, Perdita" sort="Cheshire, Perdita" uniqKey="Cheshire P" first="Perdita" last="Cheshire">Perdita Cheshire</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ayton, Scott" sort="Ayton, Scott" uniqKey="Ayton S" first="Scott" last="Ayton">Scott Ayton</name>
<affiliation><nlm:affiliation>The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bertram, Kelly L" sort="Bertram, Kelly L" uniqKey="Bertram K" first="Kelly L" last="Bertram">Kelly L. Bertram</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ling, Helen" sort="Ling, Helen" uniqKey="Ling H" first="Helen" last="Ling">Helen Ling</name>
<affiliation><nlm:affiliation>Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Abi" sort="Li, Abi" uniqKey="Li A" first="Abi" last="Li">Abi Li</name>
<affiliation><nlm:affiliation>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mclean, Catriona" sort="Mclean, Catriona" uniqKey="Mclean C" first="Catriona" last="Mclean">Catriona Mclean</name>
<affiliation><nlm:affiliation>Anatomical Pathology, Alfred Hospital, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
<affiliation><nlm:affiliation>Neuroscience Research Australia and University of New South Wales, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="O Sullivan, Sean S" sort="O Sullivan, Sean S" uniqKey="O Sullivan S" first="Sean S" last="O'Sullivan">Sean S. O'Sullivan</name>
<affiliation><nlm:affiliation>Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Revesz, Tamas" sort="Revesz, Tamas" uniqKey="Revesz T" first="Tamas" last="Revesz">Tamas Revesz</name>
<affiliation><nlm:affiliation>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Finkelstein, David I" sort="Finkelstein, David I" uniqKey="Finkelstein D" first="David I" last="Finkelstein">David I. Finkelstein</name>
<affiliation><nlm:affiliation>The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Storey, Elsdon" sort="Storey, Elsdon" uniqKey="Storey E" first="Elsdon" last="Storey">Elsdon Storey</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Williams, David R" sort="Williams, David R" uniqKey="Williams D" first="David R" last="Williams">David R. Williams</name>
<affiliation><nlm:affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Preclinical animal models implicate serotonin neurons in the pathophysiology of levodopa (l-dopa)-induced dyskinesias in Parkinson's disease (PD), but effective treatment remains elusive. We examined the relationship between serotonin and l-dopa-induced dyskinesias in a pathologically confirmed cohort of PD patients. We obtained brain tissue from 44 PD cases and 17 age-matched controls and assessed monoamine levels and the serotonin and dopamine transporters in the striatum, and the extent of dopaminergic and serotonergic cell preservation in the substantia nigra (SN) and the dorsal raphe nuclei (DRN), respectively. As expected, PD patients demonstrated a severe loss of all dopaminergic markers, including dopamine (P < 0.0001) and the dopamine transporter (P < 0.0001) in the striatum, and dopaminergic neurons (P < 0.001) in the SN, compared with controls. Marked serotonin loss was observed in the caudate (but not putamen) in PD patients compared with controls (P < 0.001), but no difference was found in the levels of the serotonin transporter in the striatum or density of serotonergic neurons in the DRN between these groups, suggesting a functional but not structural change in the serotonergic system in PD. No difference was seen in levels of serotonergic and dopaminergic markers in the striatum between PD patients with and without dyskinesias, or between cases separated according to the clinical severity of their dyskinesias. The absence of a correlation between striatal serotonin markers and the incidence and severity of l-dopa-induced dyskinesias suggests that an intact and functioning serotonergic system is not a risk factor for developing dyskinesias in PD.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="In-Process"><PMID Version="1">25649148</PMID>
<DateCreated><Year>2015</Year>
<Month>05</Month>
<Day>20</Day>
</DateCreated>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>30</Volume>
<Issue>6</Issue>
<PubDate><Year>2015</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.</ArticleTitle>
<Pagination><MedlinePgn>796-804</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.26144</ELocationID>
<Abstract><AbstractText>Preclinical animal models implicate serotonin neurons in the pathophysiology of levodopa (l-dopa)-induced dyskinesias in Parkinson's disease (PD), but effective treatment remains elusive. We examined the relationship between serotonin and l-dopa-induced dyskinesias in a pathologically confirmed cohort of PD patients. We obtained brain tissue from 44 PD cases and 17 age-matched controls and assessed monoamine levels and the serotonin and dopamine transporters in the striatum, and the extent of dopaminergic and serotonergic cell preservation in the substantia nigra (SN) and the dorsal raphe nuclei (DRN), respectively. As expected, PD patients demonstrated a severe loss of all dopaminergic markers, including dopamine (P < 0.0001) and the dopamine transporter (P < 0.0001) in the striatum, and dopaminergic neurons (P < 0.001) in the SN, compared with controls. Marked serotonin loss was observed in the caudate (but not putamen) in PD patients compared with controls (P < 0.001), but no difference was found in the levels of the serotonin transporter in the striatum or density of serotonergic neurons in the DRN between these groups, suggesting a functional but not structural change in the serotonergic system in PD. No difference was seen in levels of serotonergic and dopaminergic markers in the striatum between PD patients with and without dyskinesias, or between cases separated according to the clinical severity of their dyskinesias. The absence of a correlation between striatal serotonin markers and the incidence and severity of l-dopa-induced dyskinesias suggests that an intact and functioning serotonergic system is not a risk factor for developing dyskinesias in PD.</AbstractText>
<CopyrightInformation>© 2015 International Parkinson and Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheshire</LastName>
<ForeName>Perdita</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ayton</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bertram</LastName>
<ForeName>Kelly L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo><Affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Neurology Department, Alfred Hospital, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ling</LastName>
<ForeName>Helen</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Abi</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, University College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McLean</LastName>
<ForeName>Catriona</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Anatomical Pathology, Alfred Hospital, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Halliday</LastName>
<ForeName>Glenda M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo><Affiliation>Neuroscience Research Australia and University of New South Wales, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>O'Sullivan</LastName>
<ForeName>Sean S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo><Affiliation>Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cork University Hospital Neurosciences Department, Cork, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Revesz</LastName>
<ForeName>Tamas</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, University College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Finkelstein</LastName>
<ForeName>David I</ForeName>
<Initials>DI</Initials>
<AffiliationInfo><Affiliation>The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Storey</LastName>
<ForeName>Elsdon</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Neurology Department, Alfred Hospital, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Williams</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo><Affiliation>Department of Medicine (Neuroscience), Monash University, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Neurology Department, Alfred Hospital, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
<Keyword MajorTopicYN="N">dopamine</Keyword>
<Keyword MajorTopicYN="N">levodopa-induced dyskinesias</Keyword>
<Keyword MajorTopicYN="N">serotonin</Keyword>
<Keyword MajorTopicYN="N">striatum</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>2</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2015</Year>
<Month>2</Month>
<Day>4</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25649148</ArticleId>
<ArticleId IdType="doi">10.1002/mds.26144</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000271 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000271 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:25649148 |texte= Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25649148" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |